Clinical Associate Professor, Oral Medicine
Clinical Associate Professor, Oral Health Sciences
Clinical Associate Professor, Dental Public Health Sciences
Ms. Lloid is a recognized clinical expert on the oral tissue manifestations of bone marrow transplantation and graft versus host disease and has been involved in treating bone marrow transplant recipients. She is one of the key clinical personnel in Oral Medicine studies dealing with the management of transplant related oral mucositis, changes in oral microflora, oral tissue pathologies and other effects of transplant-related procedures. Her roles include recruiting subjects, collaborating in designing treatment and data collection protocols, organizing the collected data, ensuring study procedures were followed, collaborating on data analysis and interpretation, and collaborating on writing the resulting manuscripts.
- Lloid, Michele E. Oral Examination. In ONS Blood and Bone Marrow Stem Cell Transplant Special Interest Group Newsletter. Volume 18, Issue 1 Feb. 2007
- Schubert, MM, Eduardo, FP, Guthrie, K, Franquine, JC, Bensadoun, RJ, Lloid, ME, Eduardo, CP, Niccoli-Filho, W, Marques, MM, Migliorati, CA, Hamdi, MA. Phase III randomized double-blind placebo controlled clinical trials to determine the efficacy of low energy laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer. 15:1145-1147, 2007.
- Nash, RA, Johnston, L, Parker, P, McCune, JS, Storer, B, Slattery, JT, Furlong, T, Anasetti, C, Appelbaum, FR, Lloid, ME, Deeg, HF, Kiem, H-P, Martin, PJ, Schubert, MM, Witherspoon, RP, Forman, SJ, Blume, KJ, Storb, R. A Phase 1-2 Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation. Boil Blood Marrow Transplant. 11:495-505, 2005.
- Robien, K, Schubert, MM, Bruemmer, B, Lloid, ME, Potter, JD, Ulrich, CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol, 22(7):1268-75, 2004.